Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
Aim. A general review of treatment approaches to ulcerative colitis (UC) and the importance of oral 5-aminosalicylic acid (5-ASA) for its routine outpatient management.Key points. The choice of drug therapy for UC remission induction and maintenance is linked to the intestinal lesion extent and dise...
Saved in:
Main Authors: | Yu. P. Uspenskiy, S. V. Ivanov, Yu. A. Fominykh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2022-03-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/606 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of mesalazine at ulcerative colitis with nutritional failure
by: A. V. Korolyov, et al.
Published: (2015-03-01) -
Mesalazine use tactics in the ulcerative colitis patients
by: A. V. Korolev, et al.
Published: (2013-03-01) -
Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
by: A. Yu. Baranovsky, et al.
Published: (2012-06-01) -
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
Can anticytokine therapy prevent unfavourable course of ulcerative colitis?
by: A. Yu. Baranovsky, et al.
Published: (2013-12-01)